(Q43586097)

24 November 2017

title

Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan (English)

1 reference

24 November 2017

1 reference

B Källén

1

1 reference

24 November 2017

P E Lygner

series ordinal

2

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

41

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

351-356

1 reference

24 November 2017

cites work

Migraine and pregnancy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

Nature and etiology of the Poland anomaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

The outcome of pregnancy in women suffering from migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

Pregnancy outcome following prescription for sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

Delivery outcome after the use of antidepressants in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006351.X

10.1046/J.1526-4610.2001.111006351.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference